• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织特异性干扰素-γ丰度驱动调节性 T 细胞抑制 DC1 介导的针对肺癌的细胞毒性 T 细胞的初始激活。

Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer.

机构信息

Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA; Department of Biology, MIT, Cambridge, MA 02139, USA.

Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.

出版信息

Immunity. 2023 Feb 14;56(2):386-405.e10. doi: 10.1016/j.immuni.2023.01.010. Epub 2023 Feb 2.

DOI:10.1016/j.immuni.2023.01.010
PMID:36736322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10880816/
Abstract

Local environmental factors influence CD8 T cell priming in lymph nodes (LNs). Here, we sought to understand how factors unique to the tumor-draining mediastinal LN (mLN) impact CD8 T cell responses toward lung cancer. Type 1 conventional dendritic cells (DC1s) showed a mLN-specific failure to induce robust cytotoxic T cells responses. Using regulatory T (Treg) cell depletion strategies, we found that Treg cells suppressed DC1s in a spatially coordinated manner within tissue-specific microniches within the mLN. Treg cell suppression required MHC II-dependent contact between DC1s and Treg cells. Elevated levels of IFN-γ drove differentiation Treg cells into Th1-like effector Treg cells in the mLN. In patients with cancer, Treg cell Th1 polarization, but not CD8/Treg cell ratios, correlated with poor responses to checkpoint blockade immunotherapy. Thus, IFN-γ in the mLN skews Treg cells to be Th1-like effector Treg cells, driving their close interaction with DC1s and subsequent suppression of cytotoxic T cell responses.

摘要

局部环境因素会影响淋巴结(LNs)中的 CD8 T 细胞的初始激活。在这里,我们试图了解纵隔引流淋巴结(mLN)中特有的因素如何影响针对肺癌的 CD8 T 细胞反应。1 型传统树突状细胞(DC1)在诱导强大的细胞毒性 T 细胞反应方面表现出 mLN 特有的失败。使用调节性 T(Treg)细胞耗竭策略,我们发现 Treg 细胞以空间协调的方式在 mLN 内的组织特异性微龛中抑制 DC1。Treg 细胞的抑制需要 MHC II 依赖性的 DC1 和 Treg 细胞之间的接触。IFN-γ 的升高促使 Treg 细胞在 mLN 中分化为 Th1 样效应 Treg 细胞。在癌症患者中,Treg 细胞的 Th1 极化,而不是 CD8/Treg 细胞比例,与对检查点阻断免疫治疗的反应不良相关。因此,mLN 中的 IFN-γ 使 Treg 细胞偏向 Th1 样效应 Treg 细胞,促使它们与 DC1 密切相互作用,从而抑制细胞毒性 T 细胞反应。

相似文献

1
Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer.组织特异性干扰素-γ丰度驱动调节性 T 细胞抑制 DC1 介导的针对肺癌的细胞毒性 T 细胞的初始激活。
Immunity. 2023 Feb 14;56(2):386-405.e10. doi: 10.1016/j.immuni.2023.01.010. Epub 2023 Feb 2.
2
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8 T cell antitumor immunity.CXCR3 在调节性 T 细胞中的表达驱动其与肿瘤中 I 型树突状细胞的相互作用,从而限制 CD8 T 细胞的抗肿瘤免疫。
Immunity. 2023 Jul 11;56(7):1613-1630.e5. doi: 10.1016/j.immuni.2023.06.003. Epub 2023 Jun 30.
3
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
4
Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10.调节性 T 细胞通过对 IL-10 的分隔需求抑制急性 IFN-γ 合成,而不阻断 T 辅助细胞 1(Th1)分化。
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18336-41. doi: 10.1073/pnas.1110566108. Epub 2011 Oct 24.
5
Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.在肿瘤进展过程中,调节性T细胞和抗肿瘤效应T细胞均在同一引流淋巴结中被激活。
J Immunol. 2005 Oct 15;175(8):5058-66. doi: 10.4049/jimmunol.175.8.5058.
6
T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice.调节性T细胞导致新生小鼠对2型单纯疱疹病毒的原发性CD8 +和CD4 + T细胞反应减弱。
J Immunol. 2008 Feb 1;180(3):1556-64. doi: 10.4049/jimmunol.180.3.1556.
7
Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.α干扰素(IFN-α)预处理的树突状细胞优先刺激1型并限制肾细胞癌患者体外T细胞反应中的调节性T细胞类型。
J Immunother. 2008 Apr;31(3):254-62. doi: 10.1097/CJI.0b013e318167b023.
8
Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.通过内在的 IFN-γ-和 T-bet 依赖途径产生人类 Th1 样调节性 CD4+T 细胞。
Eur J Immunol. 2011 Jan;41(1):128-39. doi: 10.1002/eji.201040724. Epub 2010 Dec 1.
9
Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.Tc1和Tc2效应细胞疗法通过形成互补的内源性1型抗肿瘤反应的不同机制引发长期肿瘤免疫。
J Immunol. 2004 Feb 1;172(3):1380-90. doi: 10.4049/jimmunol.172.3.1380.
10
In Vivo Expansion of Endogenous Regulatory T Cell Populations Induces Long-Term Suppression of Contact Hypersensitivity.内源性调节性T细胞群体的体内扩增诱导接触性超敏反应的长期抑制。
J Immunol. 2016 Sep 1;197(5):1567-76. doi: 10.4049/jimmunol.1600508. Epub 2016 Jul 20.

引用本文的文献

1
Boosting Dendritic Cell Function in Cancer.增强癌症中树突状细胞的功能
Cancer Med. 2025 Sep;14(17):e71062. doi: 10.1002/cam4.71062.
2
Regulatory T cells in cancer anti-PD-(L)1 therapy.癌症抗PD-(L)1疗法中的调节性T细胞。
Hum Cell. 2025 Aug 25;38(5):150. doi: 10.1007/s13577-025-01280-1.
3
Orthotopically Implanted Murine Lung Adenocarcinoma Cell Lines for Preclinical Investigations.用于临床前研究的原位植入小鼠肺腺癌细胞系

本文引用的文献

1
Once upon a prime: DCs shape cancer immunity.很久以前:树突状细胞塑造癌症免疫。
Trends Cancer. 2023 Feb;9(2):172-184. doi: 10.1016/j.trecan.2022.10.006. Epub 2022 Nov 7.
2
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity.乳酸增加 CD8+T 细胞的干性以增强抗肿瘤免疫。
Nat Commun. 2022 Sep 6;13(1):4981. doi: 10.1038/s41467-022-32521-8.
3
Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes.非常规 T 细胞的淋巴迁移促进了特定部位淋巴结中的特异性免疫。
Cancers (Basel). 2025 Jul 22;17(15):2424. doi: 10.3390/cancers17152424.
4
Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy.调节性T细胞对接受新辅助化疗免疫治疗的局部晚期胃/胃食管交界部癌患者肿瘤消退的影响。
Sci Rep. 2025 Aug 8;15(1):28995. doi: 10.1038/s41598-025-14110-z.
5
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose.靶向放射性核素治疗对超过消融辐射剂量的癌细胞的影响。
Int J Mol Sci. 2025 Jul 20;26(14):6968. doi: 10.3390/ijms26146968.
6
Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints.基于调节肿瘤微环境和免疫检查点的新型肿瘤免疫治疗策略的最新进展。
Front Immunol. 2025 Jun 18;16:1529403. doi: 10.3389/fimmu.2025.1529403. eCollection 2025.
7
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial.在抗程序性死亡蛋白1(PD-1)难治性三阴性乳腺癌中动员抗原呈递肥大细胞:一项2期试验
Nat Med. 2025 Jun 25. doi: 10.1038/s41591-025-03776-7.
8
Inducible protein degradation reveals inflammation-dependent function of the T cell lineage-defining transcription factor Foxp3.可诱导的蛋白质降解揭示了T细胞谱系定义转录因子Foxp3的炎症依赖性功能。
Sci Immunol. 2025 Jun 6;10(108):eadr7057. doi: 10.1126/sciimmunol.adr7057.
9
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.2025年肺癌基础与转化研究进展——聚焦非小细胞肺癌的综述与展望
J Thorac Oncol. 2025 Jun 3. doi: 10.1016/j.jtho.2025.05.024.
10
A coordinated cellular network regulates tolerance to food.一个协调的细胞网络调节对食物的耐受性。
Nature. 2025 May 27. doi: 10.1038/s41586-025-09173-x.
Immunity. 2022 Oct 11;55(10):1813-1828.e9. doi: 10.1016/j.immuni.2022.07.019. Epub 2022 Aug 23.
4
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer.谷氨酰胺酶抑制可损害 STK11-/Lkb1 缺陷型肺癌中的 CD8 T 细胞激活。
Cell Metab. 2022 Jun 7;34(6):874-887.e6. doi: 10.1016/j.cmet.2022.04.003. Epub 2022 May 2.
5
CXCR3 regulates stem and proliferative CD8+ T cells during chronic infection by promoting interactions with DCs in splenic bridging channels.CXCR3 通过促进与脾脏桥接通道中 DC 的相互作用来调节慢性感染期间的干细胞和增殖性 CD8+T 细胞。
Cell Rep. 2022 Jan 18;38(3):110266. doi: 10.1016/j.celrep.2021.110266.
6
Type I interferon activates MHC class I-dressed CD11b conventional dendritic cells to promote protective anti-tumor CD8 T cell immunity.I 型干扰素激活 MHC Ⅰ类分子呈递的 CD11b 常规树突状细胞,促进保护性抗肿瘤 CD8 T 细胞免疫。
Immunity. 2022 Feb 8;55(2):308-323.e9. doi: 10.1016/j.immuni.2021.10.020. Epub 2021 Nov 19.
7
Lack of CD8 T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer.在非小细胞肺癌中,初始阶段缺乏 CD8 T 细胞效应分化可导致检查点阻断耐药。
Sci Immunol. 2021 Oct 29;6(64):eabi8800. doi: 10.1126/sciimmunol.abi8800.
8
Antigen dominance hierarchies shape TCF1 progenitor CD8 T cell phenotypes in tumors.抗原优势层次结构塑造了肿瘤中 TCF1 祖细胞 CD8 T 细胞的表型。
Cell. 2021 Sep 16;184(19):4996-5014.e26. doi: 10.1016/j.cell.2021.08.020.
9
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity.细胞毒性 T 细胞能够通过附加细胞毒性有效地消除癌细胞。
Nat Commun. 2021 Sep 1;12(1):5217. doi: 10.1038/s41467-021-25282-3.
10
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet.营养物质可用性和饮食对肿瘤微环境中 T 细胞代谢的调节。
Semin Immunol. 2021 Feb;52:101485. doi: 10.1016/j.smim.2021.101485. Epub 2021 Aug 27.